Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guangsi Yulin
- Development stage
- Phase 1
- Lead developer
- Capital Development Project Fund
- Administration
- Oral
01
Overview
Guangsi Yulin is a Traditional Chinese Medicine (TCM) decoction currently undergoing clinical investigation for its potential therapeutic effects in patients with asthenospermia. As a decoction, it is typically a multi-ingredient herbal preparation. The ongoing research focuses on evaluating its impact on the sperm DNA fragmentation index in affected individuals.
- Other names
- Guang Si Yu Lin Tang广嗣育麟汤
Beyond the preview
Go deeper on Guangsi Yulin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guangsi Yulin.